|
A Long-Term, Open-Label, Multicenter, Phase IV Study to Assess Longitudinal Changes on Height and Weight in Patients with MPS II Who Are Receiving Elaprase and Started Treatment With Elaprase at <6 Years of Age
|
Ongoing
|
Elaprase
|
4
|
SHPELA401
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
A MULTICENTER, PROSPECTIVE, OBSERVATIONAL, NON-INTERVENTIONAL STUDY EVALUATING THE EFFICACY AND SAFETY OF USING TOCILIZUMAB (TCZ) FOR CONFIRMED RHEUMATOID ARTHRITIS (RA) PATIENTS IN CLINICAL PRACTICE
|
Ongoing
|
tocilizumab
|
4
|
ML299336
|
King Khalid University Hospital (Riyadh), King Fahad Medical City (Riyadh)
|
|
"CLCZ696B2401-TRANSITION (A multicenter, randomized, open label, parallel group studycomparing pre-discharge and posT-discharge tReatmentinitiation with LCZ696 in heArt failure patieNtS withreduced ejectIon-fracTion hospItalized for an acutedecOmpensation eveNt (ADHF)"
|
Ongoing
|
Entresto (SACUBITRIL, VALSARTAN)
|
4
|
CZ696B2401
|
Saud Al-Babtain Cardiac Center (Dammam), King Faisal Specialist Hospital and Research Center (Jeddah), King Faisal Specialist Hospital and Research Center (Riyadh), King Khalid University Hospital (Riyadh)
|
|
"A 52-Week, Open-Label, Prospective, Multicenter, International Study of a Transition tothe Paliperidone Palmitate 3-Month Formulation in Patients with SchizophreniaPreviously Stabilized on the Paliperidone Palmitate 1-Month Formulation"
|
Ongoing
|
paliperidone
|
3
|
R092670SCH3015
|
Jeddah psychiatric hospital, Al-Amal Complex for mental health (Dammam)
|
|
"A Randomized controlled Trial of Influenza Vaccineto Reduce Adverse Vascular Events"
|
Ongoing
|
Vaxigrip
|
3
|
version 2
|
King Khalid University Hospital (Riyadh), King Abdulaziz University Hospital (Jeddah), King Fahad Medical City (Riyadh), Madinah Cardiac Center
|
|
"Study H9X-MC-GBGC is a Phase 3, randomized, double-blind, placebo-controlled trial withan open-label extension that investigates the effect of the addition of dulaglutide (0.75 and1.5 mg/week) or placebo weekly to metformin and/or basal insulin on change from baselinein hemoglobin A1c at 26 weeks in children and adolescents with type 2 diabetes mellitus"
|
Ongoing
|
Dulaglutide 0.75 /1.5 mg
|
3
|
H9X-MC-GBGC
|
King Khalid University Hospital (Riyadh), International Medical Center (Jeddah)
|
|
RAINBOW study: a randomized, controlled study evaluating the efficacy and safety of Ranibizumab compared with laser therapy for the treatment of Infants BOrn prematurely With retinopathy of prematurity
|
Ongoing
|
Ranibizumab
|
3
|
CRFB002H2301 V 01
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
RAINBOW study: a randomized, controlled study evaluating the efficacy and safety of Ranibizumab compared with laser therapy for the treatment of Infants BOrn prematurely With retinopathy of prematurity
|
Ongoing
|
Ranibizumab
|
3
|
CRFB002H2301 V 01
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
An Open-Label, Randomized Phase 3 Trial of Nivolumab, or Nivolumab plus Ipilimumab, or Nivolumab plus platinum doublet chemotherapy versus platinum doublet chemotherapy in Subjects with Chemotherapy-Naïve Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)
|
Terminated
|
NIVOLUMAB/IPILIMUMAb
|
3
|
CA209-227
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
Phase 2 study of 5 Days azacytidine priming prior to fludarabine, cytarabine and G-CSF combination for patients with relapsed or refractory AML.
|
Ongoing
|
Vidaza
|
2
|
Version 1.1
|
King Fahad Medical City (Riyadh)
|
